Menu Back toSession 7: Prescriber and Patient Confidence with Biosimilar Use
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Session 7: Prescriber and Patient Confidence with Biosimilar Use
Hillel P Cohen, PhD
- Executive Director, Scientific Affairs
- Sandoz Inc., United States
In this session we will review how prescribers and pharmacists are integrating biosimilars into their practices and how biosimilars are being received by patients. We will also review awareness and education efforts that have been implemented, focusing on what has worked and what has not worked as expected.
Learning Objective : At the conclusion of this session, participants should be able to:
- Identify programs implemented to educate healthcare professionals and their patients so that biosimilars are accepted and used
- Understand why some educational programs have been more successful than others
- Gain an appreciation for aspects of biosimilarity that are now well accepted as well as areas of residual concern
Best Practices for Biosimilar Integration into Routine Clinical Care
Shubha Bhat, PharmD, MS
- Ambulatory Care Clinical Pharmacy Specialist - Gastroenterology
- Boston Medical Center, Center for Digestive Disorders & Crohn's and Colitis, United States
Developing a Biosimilar Implementation Plan: Creating a toolkit for success
Ryan Haumschild, PharmD, MBA, MS
- Director of Pharmaceutical Sciences
- Emory Healthcare, United States
Ali McBride, PharmD, MS
- Clinical Coordinator
- The University of Arizona Cancer Center, United States